NAN Stock Overview
Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 4/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
My Notes
NewNotes are coming soon
Nanosonics Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$4.82 |
52 Week High | AU$5.42 |
52 Week Low | AU$2.87 |
Beta | 1.63 |
1 Month Change | 12.35% |
3 Month Change | 12.88% |
1 Year Change | -5.12% |
3 Year Change | -29.64% |
5 Year Change | 72.76% |
Change since IPO | 487.80% |
Recent News & Updates
This Is Why Nanosonics Limited's (ASX:NAN) CEO Compensation Looks Appropriate
Nov 11A Look At The Fair Value Of Nanosonics Limited (ASX:NAN)
Oct 28What Does Nanosonics Limited's (ASX:NAN) Share Price Indicate?
Oct 06Recent updates
This Is Why Nanosonics Limited's (ASX:NAN) CEO Compensation Looks Appropriate
Nov 11A Look At The Fair Value Of Nanosonics Limited (ASX:NAN)
Oct 28What Does Nanosonics Limited's (ASX:NAN) Share Price Indicate?
Oct 06A Look At The Fair Value Of Nanosonics Limited (ASX:NAN)
Jul 18At AU$3.36, Is Nanosonics Limited (ASX:NAN) Worth Looking At Closely?
Jun 26Nanosonics (ASX:NAN) Will Want To Turn Around Its Return Trends
Jun 07A Look At The Intrinsic Value Of Nanosonics Limited (ASX:NAN)
Mar 08Nanosonics Limited (ASX:NAN) Analysts Just Cut Their EPS Forecasts
Feb 15Is Now The Time To Look At Buying Nanosonics Limited (ASX:NAN)?
Feb 02Nanosonics Limited's (ASX:NAN) CEO Looks Due For A Compensation Raise
Nov 12Returns Are Gaining Momentum At Nanosonics (ASX:NAN)
Aug 03An Intrinsic Calculation For Nanosonics Limited (ASX:NAN) Suggests It's 21% Undervalued
Mar 30Returns On Capital - An Important Metric For Nanosonics (ASX:NAN)
Mar 15Time To Worry? Analysts Are Downgrading Their Nanosonics Limited (ASX:NAN) Outlook
Feb 28Nanosonics Limited's (ASX:NAN) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Feb 19Is There Now An Opportunity In Nanosonics Limited (ASX:NAN)?
Feb 07What Did Nanosonics' (ASX:NAN) CEO Take Home Last Year?
Jan 26How Much Of Nanosonics Limited (ASX:NAN) Do Insiders Own?
Jan 14Here's Why Nanosonics's (ASX:NAN) Statutory Earnings Are Arguably Too Conservative
Jan 01Estimating The Intrinsic Value Of Nanosonics Limited (ASX:NAN)
Dec 20Is There More Growth In Store For Nanosonics' (ASX:NAN) Returns On Capital?
Dec 07Can You Imagine How Elated Nanosonics' (ASX:NAN) Shareholders Feel About Its 302% Share Price Gain?
Nov 25Is Nanosonics' (ASX:NAN) Share Price Gain Of 250% Well Earned?
Jul 28Is Nanosonics Limited (ASX:NAN) Potentially Undervalued?
Jul 13A Look At The Fair Value Of Nanosonics Limited (ASX:NAN)
Jun 28Shareholder Returns
NAN | AU Medical Equipment | AU Market | |
---|---|---|---|
7D | -1.6% | -2.4% | 0.6% |
1Y | -5.1% | 2.2% | 3.5% |
Return vs Industry: NAN underperformed the Australian Medical Equipment industry which returned 2.2% over the past year.
Return vs Market: NAN underperformed the Australian Market which returned 3.5% over the past year.
Price Volatility
NAN volatility | |
---|---|
NAN Average Weekly Movement | 8.1% |
Medical Equipment Industry Average Movement | 9.7% |
Market Average Movement | 8.5% |
10% most volatile stocks in AU Market | 15.7% |
10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: NAN is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: NAN's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | 425 | Michael Kavanagh | https://www.nanosonics.com.au |
Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution.
Nanosonics Limited Fundamentals Summary
NAN fundamental statistics | |
---|---|
Market Cap | AU$1.46b |
Earnings (TTM) | AU$3.74m |
Revenue (TTM) | AU$120.32m |
389.0x
P/E Ratio12.1x
P/S RatioIs NAN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NAN income statement (TTM) | |
---|---|
Revenue | AU$120.32m |
Cost of Revenue | AU$28.42m |
Gross Profit | AU$91.91m |
Other Expenses | AU$88.16m |
Earnings | AU$3.74m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 0.012 |
Gross Margin | 76.38% |
Net Profit Margin | 3.11% |
Debt/Equity Ratio | 0% |
How did NAN perform over the long term?
See historical performance and comparison